Dental massive Envista names Paul Keel new CEO

BREA, Calif., US: Envista Holdings has appointed Paul Keel as its new CEO and a member of its board of administrators, efficient from 1 Might. The corporate owns greater than 30 dental manufacturers, together with Nobel Biocare, Ormco, DEXIS and Kerr. It introduced in February that it was once in quest of a successor to Amir Aghdaei, who will proceed to improve the transition as a senior adviser.

Keel’s “sturdy monitor file as CEO of a public, different, international innovation corporate makes him the correct chief for Envista at this degree in our enlargement adventure,” mentioned Scott Huennekens, chairman of Envista, in a press unlock. “His pertinent aggregate of increasing enlargement and operational excellence along with his enjoy within the scientific and oral care markets make him uniquely certified to guide Envista in our project to digitise, personalise, and democratise dental care,” Huennekens added.

Keel commented: “It’s an ideal honour to guide Envista at this thrilling time in our deep and wealthy historical past. I do know and recognize the corporate and business. I’m overjoyed to construct on Envista’s sturdy basis, doing ever extra to serve all our stakeholders—our shoppers, their sufferers, our colleagues, our communities and our shareholders.”

Keel maximum not too long ago served as CEO of worldwide era corporate Smiths Staff. He up to now spent 16 years at 3M, the place he served in quite a lot of management roles, together with staff president of the corporate’s client trade staff, president of 3M Clinical and president of 3M’s distinctiveness dental trade. Previous to that, he held positions of accountability at Normal Electrical, McKinsey & Corporate and Normal Turbines. Paul holds a BA from Carleton Faculty and an MBA from Harvard Industry College, each in america.